Cocktail Event – January 25, 2017

helius-logoHelius Medical Technologies (HMT) is a medical device company focused on neurological wellness. The company is committed to leading the advancement of unique and non-invasive platform technologies designed to amplify the brain’s powerful ability to heal itself. Helius intends to file for FDA clearance for the PoNS™ device. PoNS is an investigational medical device currently being studied for the treatment of balance disorder symptoms related to mild to moderate Traumatic Brain Injury (TBI). TSX: HSM

Helius Portfolio Presentation January 2017 Paul Benwell

Acr153742700648916-14737 copyPolyMet Mining Corp. is a publicly-traded mine development company focused on permitting, building and operating the NorthMet copper-nickel precious metals project through its wholly owned subsidiary, Poly Met Mining, Inc. Poly Met recently announced approval from U.S. Forest Service  authorizing the land exchange for PolyMet’s NorthMet copper-nickel-precious metals project located in the established Mesabi Iron Range mining district in northeastern Minnesota. TSX: POM; NYSE MKT: PLM


Acr153742700648916-5025 copyCHX Technologies is a private pharmaceutical company with multiple drug approvals for the first-ever preventive treatment for dental decay in high-risk adults, Prevora. CHX plans to submit a new drug application for Pevora to the FDA shortly and currently has approximately 40 dental practices awaiting Prevora. CHX Fact Sheet


Posted in SmallCap Penthouse 5à7.